13D Filing: Sand Grove Capital Partners and Syneron Medical Ltd. (ELOS)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
SAND GROVE CAPITAL MANAGEMENT L 1,501,205 9. 1,501,205 11. 1,501,205 4.3%
Simon Davies
Simon Davies
Sand Grove Capital Partners

Page 1 of 4 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
SYNERON MEDICAL LTD
(Name of Issuer)
Common Stock
(Title of Class of Securities)
M87245102
(CUSIP Number)
Jonathan Groom
4th floor, 35 Dover Street
London
W1S 4NQ
+44 (0) 203 770 8613
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
10 May 2017
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 2 of 4 – SEC Filing

CUSIP No. M87245102
13D
Page 2 of 4 Pages
1.
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

SAND GROVE CAPITAL MANAGEMENT LLP
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
(b)
3.
SEC USE ONLY
4.
SOURCE OF FUNDS (see instructions)

OO
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6.
CITIZENSHIP OR PLACE OF ORGANIZATION

United Kingdom
NUMBER OF SHARES BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7.
SOLE VOTING POWER

1,501,205
8.
SHARED VOTING POWER

9.
SOLE DISPOSITIVE POWER

1,501,205
10.
SHARED DISPOSITIVE POWER
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,501,205
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

4.3%
14.
TYPE OF REPORTING PERSON (see instructions)

PN

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 3 of 4 – SEC Filing

CUSIP No. M87245102
13D
Page 3 of 4 Pages
Item 1. Security and Issuer.
Item 2. Identity and Background.
Item 3. Source or Amount of Funds or Other Consideration.
Item 4. Purpose of Transaction.
Item 5. Interest in Securities of the Issuer.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
Item 7. Material to Be Filed as Exhibits.

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 4 of 4 – SEC Filing

CUSIP No. M87245102
13D
Page 4 of 4 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
COMPANY NAME
Sand Grove Capital Management LLP
Insert Name
Daniel McLachlan – Operations Analyst
Insert Title
11 May 2017
Insert Date

 

Follow Syneron Medical Ltd. (NASDAQ:ELOS)